BIOEvs its industry peers
A metric-by-metric comparison of BIOE against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOEThis | — | — | — | — | 485.8%#1 | 168.5%#1 | 47.4%#1 | 38.3%#1 | 37.9%#1 | 7#1 | — | — |
| BDRX | $566.8B#1 | — | — | — | — | — | — | — | — | — | — | — |
| BEIGF | — | — | — | — | 40.2%#3 | 144.5%#2 | 8.4%#2 | 4.9%#2 | 31.0%#2 | 7#1 | — | — |
| BGM | — | — | — | — | 51.1%#2 | -1282.1%#6 | -33.2%#3 | -5.1%#3 | — | — | — | — |
| BIOM | — | — | — | — | — | 16.6%#4 | — | — | — | — | — | — |
| BIXT | — | — | — | — | -22.5%#4 | 10.3%#5 | -964.3%#5 | — | — | — | — | — |
| BLRX | $4.5B#2 | — | 246.8x#1 | 3805.6x#1 | -95.9%#5 | 78.0%#3 | -871.8%#4 | -11.1%#4 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice